Thrombopoietin產(chǎn)品信息
英文名稱:Thrombopoietin
中文名稱:血小板生成素
靶點(diǎn)別稱:THPO,MGC163194,MGDF,MKCSF,ML,MPLLG,TPO,THCYT1
物種:Human
屬性:Protein
標(biāo)記:Unconjugated
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
無菌(Sterility)
The sterility testing was performed by membrane filtration method.
支原體(Mycoplasma)
Negative.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
1. -20°C to -70°C for 12 months in lyophilized state;
2. -70°C for 3 months under sterile conditions after reconstitution.
Thrombopoietin分子背景
血小板生成素(TPO)是一種332個(gè)氨基酸的糖蛋白,主要在肝臟中產(chǎn)生,是血小板產(chǎn)生的主要生理調(diào)節(jié)因子。TPO結(jié)合TPO受體,激活JAK和STAT通路,從而刺激巨核細(xì)胞生長和血小板生成。此外,進(jìn)一步的研究發(fā)現(xiàn),血小板生成素是促進(jìn)骨髓消融后造血反彈的關(guān)鍵細(xì)胞因子,其轉(zhuǎn)錄物由多種細(xì)胞來源表達(dá)。
關(guān)鍵字: Thrombopoietin;Thrombopoietin蛋白;血小板生成素;THPO;THPO蛋白;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。